<?xml version="1.0" encoding="UTF-8"?>
<fig id="pone.0230878.g003" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0230878.g003</object-id>
 <label>Fig 3</label>
 <caption>
  <title>Resistance of HIV-1 to antiretroviral drugs.</title>
  <p>The evaluated samples were collected in the period between 2008 and 2017 in the state of Maranhão, Brazil. In the period 2008–2012, data of 2010 were excluded. ATV/r: Atazavanir/ritonavir, DRV/r: Darunavir/ritonavir, LPV/r: Lopinavir/ritonavir, ABC: Abacavir, AZT: Zidovudine, FTC: Emtricitabine, 3TC: Lamivudine, TDF: Tenofovir, EFV: Efavirenz, ETR: Etravirine, NVP: Nevirapine, RPV: Rilpivirine.</p>
 </caption>
 <graphic xlink:href="pone.0230878.g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
